Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathrin Ritter

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell CarcinomaIvelina Spassova, Selma Ugurel, Patrick Terheyden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell CarcinomaKaiji Fan, Cathrin Ritter, Paul Nghiem, et al.
Cancer Immunology Research|July 4, 2019
MERTK Acts as a Costimulatory Receptor on Human CD8<sup>+</sup> T CellsMarlies J W Peeters, Donata Dulkeviciute, Arianna Draghi, et al.
The Journal of Clinical Investigation|May 20, 2020
Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapyLina Such, Fang Zhao, Derek Liu, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell CarcinomaIvelina Spassova, Selma Ugurel, Patrick Terheyden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell CarcinomaKaiji Fan, Cathrin Ritter, Paul Nghiem, et al.
Cancer Immunology Research|July 4, 2019
MERTK Acts as a Costimulatory Receptor on Human CD8<sup>+</sup> T CellsMarlies J W Peeters, Donata Dulkeviciute, Arianna Draghi, et al.
The Journal of Clinical Investigation|May 20, 2020
Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapyLina Such, Fang Zhao, Derek Liu, et al.
Pageof 3